Skip to main content

Table 1 Demographic characteristics of patients undergoing isolated major surgery

From: Racial disparities in the use of blood transfusion in major surgery

Characteristics

CABG

Total hip replacement

Colectomy

White

Black

White

Black

White

Black

(n = 23,113)

(n = 2,736)

(n = 37,888)

(n = 5,045)

(n = 6,861)

(n = 1,394)

RBC transfused (%)

10,284 (44.5)

1,599 (58.4)

10,680 (28.2)

1,701 (33.7)

1,341 (19.6)

314 (22.5)

Age, median (IQR)

65 (58-73)

61 (55-69)

63 (55-72)

57 (49-65)

62 (50-73)

59 (48-68)

Female

5,124 (22.2)

1,135 (41.5)

20,552 (54.2)

2,738 (54.3)#

3,403 (49.6)

720 (51.7)#

Primary payer

      

Private

8,802 (38.1)

761 (27.8)

17,849 (47.1)

1,772 (35.1)

3,082 (44.9)

389 (27.9)

Medicare

11,441 (49.5)

1,291 (47.2)

17,067 (45.1)

2,035 (40.3)

2,984 (43.5)

540 (38.7)

Medicaid

1,032 (4.5)

330 (12.1)

1,446 (3.8)

798 (15.8)

338 (4.9)

236 (16.9)

Self-pay

697 (3.0)

164 (6.0)

324 (0.9)

108 (2.1)

209 (3.1)

105 (7.5)

Other

1,120 (4.9)

181 (6.6)

1,163 (3.1)

324 (6.4)

241 (3.5)

122 (8.8)

Admission status

      

Emergent

4,749 (20.6)

817 (29.9)

1,099 (2.9)

141 (2.8)#

1,508 (22.0)

464 (33.3)

Urgent

6,715 (29.1)

763 (27.9)

895 (2.4)

170 (3.4)

702 (10.2)

141 (10.1)#

Elective

11,615 (50.3)

1,152 (42.1)

35,818 (94.5)

4,725 (93.7)

4,602 (67.1)

763 (54.7)

Trauma

6 (0.03)

1 (0.04)

67 (0.2)

7 (0.2)#

43 (0.6)

22 (1.6)

Comorbidity

      

Congestive heart failure

59 (0.3)

14 (0.5)

877 (2.3)

169 (3.4)

364 (5.3)

101 (7.3)

Valve disease

29 (0.1)

5 (0.2)#

1,475 (3.9)

96 (1.9)

326 (4.8)

45 (3.2)

Pulmonary circ disease

19 (0.1)

3 (0.1)#

300 (0.8)

76 (1.5)

104 (1.5)

31 (2.2)#

Periphery vascular disease

3,557 (15.4)

490 (17.9)

756 (2.0)

96 (1.9)#

333 (4.9)

57 (4.1)#

Hypertension

16,100 (69.7)

1,706 (62.4)

19,924 (52.6)

3,250 (64.4)

3,129 (45.6)

818 (58.7)

Paralysis

111 (0.5)

22 (0.8)

108 (0.3)

19 (0.4)#

61 (0.9)

18 (1.3)#

Other neurology disorder

715 (3.1)

84 (3.1)#

1,306 (3.5)

147 (2.9)

295 (4.3)

49 (3.5)#

Chronic pulmonary disease

4,557 (19.7)

520 (19.0)#

4,732 (12.5)

806 (16.0)

987 (14.4)

176 (12.6)#

Diabetes w/o complications

7,148 (30.9)

1,071 (39.1)

3,816 (10.1)

827 (16.4)

889 (13.0)

285 (20.4)

Diabetes with complications

1,757 (7.6)

319 (11.7)

417 (1.1)

83 (1.65)

136 (2.0)

35 (2.5)#

Hypothyroid

2,316 (10.0)

160 (5.9)

5,082 (13.4)

288 (5.7)

703 (10.3)

64 (4.6)

Renal failure

3,129 (13.5)

711 (26.0)

1,321 (3.5)

357 (7.1)

395 (5.8)

123 (8.8)

Liver disease

411 (1.8)

58 (2.1)#

535 (1.4)

127 (2.5)

170 (2.5)

26 (1.9)#

Peptic ulcer

9 (0.04)

0 (0.0)#

7 (0.02)

0 (0.0)#

3 (0.04)

1 (0.07)#

AIDS

27 (0.12)

15 (0.6)

88 (0.2)

69 (1.4)

8 (0.1)

7 (0.5)

Lymphoma

122 (0.5)

11 (0.4)#

240 (0.6)

34 (0.7)#

47 (0.7)

7 (0.5)#

Metastatic cancer

50 (0.2)

3 (0.1)#

225 (0.6)

21 (0.4)#

962 (14.0)

208 (14.9)#

Tumor w/o metastasis

328 (1.4)

44 (1.6)#

263 (0.7)

23 (0.5)

205 (3.0)

43 (3.1)#

Rheumatoid arthritis

478 (2.1)

66 (2.4)#

1,460 (3.9)

335 (6.6)

179 (2.6)

31 (2.2)#

Coagulopathy*

121 (0.5)

12 (0.4)#

183 (0.5)

14 (0.3)

32 (0.5)

4 (0.3)#

Obese

4,564 (19.8)

566 (20.7)#

4,955 (13.1)

864 (17.1)

696 (10.1)

178 (12.8)

Weight loss

204 (0.9)

34 (1.2)#

110 (0.3)

26 (0.5)

317 (4.6)

91 (6.5)

Fluid electrolyte disorder

1,112 (4.8)

195 (7.1)

718 (1.9)

108 (2.1)#

467 (6.8)

149 (10.7)

Blood loss anemia

48 (0.2)

14 (0.5)

62 (0.2)

9 (0.2)#

93 (1.4)

47 (3.4)

Deficiency anemia

1,880 (8.1)

476 (17.4)

1,913 (5.1)

423 (8.4)

934 (13.6)

262 (18.8)

Alcohol abuse

804 (3.5)

135 (4.9)

693 (1.8)

137 (2.7)

167 (2.4)

66 (4.7)

Drug abuse

296 (1.3)

161 (5.9)

334 (0.9)

170 (3.4)

85 (1.2)

58 (4.2)

Psychoses

374 (1.6)

49 (1.8)#

657 (1.7)

119 (2.4)

154 (2.2)

49 (3.5)

Depression

1,906 (8.3)

149 (5.5)

4,660 (12.3)

394 (7.8)

628 (9.2)

68 (4.9)

  1. Unless otherwise indicated, results are presented as number of patients and percentages.
  2. Abbreviations: IQR inter-quartile range, AIDS acquired immune deficiency syndrome. All p values < 0.05 except marked with #.
  3. *This refers to the newly defined coagulopathy used in the analysis, which recoded ICD-9 codes of 286.6, 286.7, 286.9, 287.4, and 287.5 as 0 for this comorbidity variable. The reason for the recoding is that the coagulopathy codes could be complications related to blood transfusion.